However, although above results implied CDKN2A is an oncogene in breast cancer, the expression level of CDKN2A is negatively related with drug score (CTX, DTX, PTX, DDP, and TAM) (Figure 12G). The gene discussed is CDKN2A; the disease is breast carcinoma.